University research records
King Edward Medical University
9 imported, source-linked research records. Published in the last two years.
Published in the last two years
Back to university profile →9 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to King Edward Medical University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–9 of 9 matching records. Counts update as records arrive.
Real-world safety and effectiveness of empagliflozin (Diampa®) alone or in combination with metformin (Diampa-M®) in patients with type 2 diabetes mellitus in Pakistan: a multicenter observational study
September 28, 2026 · 0 citations · Open access
Open original record →Efficacy of Dapagliflozin in Anemic patients with Heart failure: A Systematic review and Meta-Analysis
February 12, 2026 · 0 citations · Open access
Open original record →Guideline-Directed Medical Therapy for Diabetic Kidney Disease: Advances in Primary and Secondary Prevention
January 19, 2026 · 3 citations · Open access
Open original record →Abstract 4371168: Comparative Outcomes of GLP-1 Agonists vs SGLT2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure: A Propensity-Matched Multicenter Retrospective Analysis
November 3, 2025 · 0 citations
Open original record →A Comparison of Cardiovascular Benefits of Dapagliflozin and Empagliflozin in Type 2 Diabetes: A Systematic Review and Meta-analysis
October 10, 2025 · 0 citations · Open access
Open original record →Effectiveness of SGLT2 Inhibitors in Improving Functional Capacity and Reducing Hospitalizations in Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Randomized Controlled Trials
September 15, 2025 · 0 citations · Open access
Open original record →Evaluating the Clinical Outcomes of Empagliflozin in Heart Failure Patients With Preserved Ejection Fraction: A Systematic Review
May 13, 2025 · 0 citations · Open access
Open original record →Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
May 1, 2025 · 5 citations · Open access
Open original record →Efficacy and Safety of Pioglitazone Add‐On in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
May 1, 2025 · 10 citations · Open access
Open original record →